Multiomic liquid biopsy: emerging applications in disease quantification, biomarker detection, molecular phenotyping, and cancer signal of origin prediction
The field of cancer-related liquid biopsy, largely defined as plasma circulating tumor DNA (ctDNA) analysis by next-generation sequencing (NGS), is rapidly evolving from genomics-only approaches to multiomic assays that add components such as DNA fragmentomics and epigenomics, with or without proteomics, to a genomic b...